Parameter
| Biomarker | S100B | Full name | S100 Calcium-Binding Protein B | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis, Monitoring |
| Disease | Epilepsy | Disease Subtypes | / | ||
| Organ | Brain | Test Sample / Technology Platform | Serum (ELISA) | ||
| Pathobiological Mechanisms | Released after astrocyte activation, involved in neuroinflammation and blood-brain barrier disruption, reflecting the degree of brain injury. | ||||
| Clinical Availability Status | Under clinical validation | ||||
| Notes and Dynamics | Serum S100B peaks within 24 hours after TLE seizures, and levels are positively correlated with the degree of hippocampal sclerosis. | ||||